Contemporary management of type 1 diabetes mellitus in pregnancy

Obstetrical and Gynecological Survey

Volumn 59, Issue 8, 2004, Pages 628-636

  Bernasko, James ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE; INFUSION FLUID; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; STEROID;

ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; DRUG DOSE REGIMEN; ECONOMIC ASPECT; GENERAL PRACTITIONER; HEALTH CARE UTILIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MATERNAL CARE; MATERNAL MORBIDITY; MEDICAL CARE; MEDICAL SPECIALIST; OBSTETRIC CARE; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROGENY; REVIEW; STANDARD;

DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; PRE-ECLAMPSIA; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PRENATAL CARE;

EID: 3242770737     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-200408000-00024     Document Type: Review

References (53)

1. Foster DW. Diabetes mellitus. In: Fauci A, Braunwald E, Isselbacher K, et al., eds. Harrison's Principles of Internal Medicine, 14th ed. 1998:2060-2081.
2. Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993;42:359-362.
3. Palmer JP, Hirsch IB. What's in a name? Latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1. Diabetes Care 2003;26:536-538.
4. Pozzilli P, DiMario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult). Definition, characterization, and potential prevention. Diabetes Care 2001;24:1460-1467.
5. American Diabetes Association. Available at: www.diabetes.org. 2003.
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986.
7. Janz NK, Herman WH, Becker MP, et al. Diabetes in pregnancy. Factors associated with seeking pre-conception care. Diabetes Care 1995;18:157-165.
8. Holing EV, Beyer CS, Brown ZA, et al. Why don't women with diabetes plan their pregnancies? Diabetes Care 1998;21:889-895.
9. Ray JG, O'Brien TE, Chan WS. Pre-conception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q J Med 2001;4:435-444.
10. Diabetes and Pregnancy Group, France. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003;6:2990-2993.
11. 1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 1981;304: 1331-1334.
12. 1c values in early pregnancy. BMJ 1984;289:345-346.
13. Rosenn B, Miodovnik M, Combs A, et al. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 1994;84: 515-520.
14. Kitzmiller JL, Gavin LA, Gin GD, at al. Preconception management of diabetes continued through early pregnancy prevents the excess frequency of major congenital anomalies in infants of diabetic mothers. JAMA 1991;265:731-736.
15. Reece EA, Homko CJ, Wu Y-K. Multifactorial basis of the syndrome of diabetic embryopathy. Teratology 1996;54:171-182.
16. Kjos SL. Postpartum care of the woman with diabetes. Clin Obstet Gynecol 2000;43:75-86.
17. Petersen KR, Skouby SO, Vedel P, et al. Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipoprotein metabolism. Diabetic Care 1995:800-804.
18. White P. Pregnancy complicating diabetes. Am J Med 1949: 609-616.
19. Chew EY, Mills JO, Metzger BE, et al. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Metabolic control and progression of retinopathy. Diabetes Care 1995;18:631-637.
20. Kimmerle R, Kab R-P, Cupisti S, et al. Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia 1995;38:227-235.
21. Miodovnik M, Rosenn BM, Khoury JC, et al. Does pregnancy increase the risk for development and progression of diabetic nephropathy? Am J Obstet Gynecol 1996:1180-1191.
22. Gordon M, Landon MB, Samuels P, et al. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol 1996;87:401-409.
23. Reece EA, Leguizamen G, Homko C. Stringent controls in diabetic nephropathy associated with optimization of pregnancy outcomes. J Matern Fetal Med 1998;7:213-216.
24. Reece EA, Leguizamen G, Homko C. Pregnancy performance and outcomes associated with diabetic nephropathy. Am J Perinatol 1998;15:413-421.
25. Leguizamon G, Reece EA. Effect of medical therapy on progressive nephropathy: influence of pregnancy, diabetes and hypertension. J Matern Fetal Med 2000;9:70-78.
26. Purdy LP, Hantsch CE, Molitch ME, et al. Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care 1996;19:1067-1074.
27. Ekbom P, Damm P, Feldt-Rasmussen B, et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001;24:1739-1744.
28. Nelson DM, Barrows HJ, Clapp DH, et al. Glycosylated serum protein levels in diabetic and nondiabetic pregnant patients: an indicator of short-term glycemic control in the diabetic patient. Am J Obstet Gynecol 1985;151:1042-1047.
29. 1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose levels. Diabetes Care 1995;18: 440-447.
30. Rey E, Attie C, Bonin A. The effects of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol 1999;181:202-206.
31. Gold AE, Reilly R, Little J, et al. The effect of glycemic control in the pre-conception period and early pregnancy on birth weight in women with IDDM. Diabetes Care 1998;21:535-538.
32. Jovanovic-Peterson L, Peterson CM, Reed GF, et al. National Institute of Child Health and Human Development-Diabetes in Early Pregnancy Study. Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study. Am J Obstet Gynecol 1991;164:103-111.
33. Combs CA, Gunderson E, Kitzmiller JL, et al. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992;15:1251-1257.
34. 1c affected by glycemic instability? Diabetes Care 2003;26:2728-2733.
35. Reiher H, Fuhrmann K, Noack S, et al. Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care 1983;6:446-451.
36. Raychaudhuri K, Maresh MJA. Glycemic control throughout pregnancy and fetal growth and insulin-dependent diabetes. Obstet Gynecol 2000;95:190-194.
37. Wong SF, Chan FY, Oates JJN, et al. Fetal growth spurt and pregestational diabetic pregnancy. Diabetes Care 2002;25: 1681-1684.
38. Kimmerle R, Heinemann L, Delecki A, et al. Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type 1 diabetic women. Diabetes Care 1992;15:1034-1037.
39. Rosenn B, Miodovnik M, Holcberg G, et al. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995;85: 417-422.
40. Weissberg-Benchel J, Antisdal-Lomaglio J, Seshandri R. Insulin pump therapy. A meta-analysis. Diabetes Care 2003;26: 1079-1087.
41. Coustan D, Reece E, Sherwin R, et al. A randomized clinical trial of the insulin pump versus intensive conventional therapy in diabetic pregnancies. JAMA 1986;255:631-636.
42. Lepore G, Dodesini AR, Nosari I, et al. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment. Diabetes Care 2003;26:1321.
43. Rossetti P, Pampanelli S, Fanelli C, et al. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime. Diabetes Care 2003; 26:1490-1496.
44. Owens DR, Zinman B, Bolli GB. Insulins today and beyond. Lancet 2001;358:739-746.
45. Kim D, Mudaliar S, Chinnapongse S, et al. Dose-response relationship of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes. Diabetes Care 2003;26:2842-2847.
46. Delgado J, Greene M, Winkelman J, et al. Comparison of disaturated phosphatidylcholine and fetal lung maturity surfactant/albumin ratio in diabetic and nondiabetic pregnancies. Am J Clin Pathol 2000;113:233-239.
47. Reller M, Tsang R, Meyer R, et al. Relationship of prospective diabetes control in pregnancy to neonatal cardiorespiratory function. J Pediatr 1985;106:86-90.
48. Sadovsky E. Fetal movements and fetal health. Semin Perinatol 1981;5:131-136.
49. Golde S, Platt L. Antepartum testing in diabetes. Clin Obstet Gynecol 1985;28:516-519.
50. Lauenborg J, Mathiesen E, Ovesen P, et al. Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care 2003;26:1385-1389.
51. Coustan DR. Delivery: timing, mode and management. In: Reece EA, Coustan DR, eds. Diabetes Mellitus in Pregnancy. Edinburgh: Churchill Livingstone, 1995:353-360.
52. Drury MI, Stronge JM, Foley ME. Pregnancy in the diabetic patient: timing and mode of delivery. Obstet Gynecol 1983; 62:279.
53. Herman W, Janz N, Becker M, et al. Diabetes and pregnancy. Preconception care, pregnancy outcomes, resource utilization and costs. J Reprod Med 1999;44:33-38.